Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.058 AUD | -3.33% | -6.45% | +163.64% |
Apr. 30 | Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury | MT |
Apr. 18 | Transcript : Nyrada Inc., Q3 2024 Earnings Call, Apr 18, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+163.64% | 7.13M | |
+39.82% | 731B | |
+31.34% | 586B | |
-7.31% | 348B | |
+14.23% | 319B | |
+0.86% | 273B | |
+13.47% | 235B | |
-6.63% | 203B | |
+7.49% | 202B | |
+4.51% | 159B |
- Stock Market
- Equities
- NYR Stock
- News Nyrada Inc.
- Nyrada Begins Animal Testing on NYR-BI03 Brain Injury Program